Tag: English

New York, NY – April 20, 2026 – Following a challenge brought by Alcon, Inc., BBB National Programs’ National Advertising Division determined that Johnson & Johnson Vision Care, Inc. (JJVC) had a reasonable basis for the claim “MAX comfort. MAX clarity.” for its ACUVUE® Oasys Max 1-Day contact lenses, however, recommended that JJVC discontinue or modify its superiority and “2X” comparative claims.

JJVC and Alcon are competitors in the soft contact lens market and each offers a range of daily disposable (single-use) and reusable lenses designed for different consumer needs.

Alcon challenged advertising claims made by JJVC in connection with the launch and promotion of its Oasys Max lenses. The challenged claims appeared in advertising for Oasys Max directed to consumers and eye care professionals (ECPs), including on the JJVC consumer-facing website and in professional marketing materials such as trade show materials and an ECP brochure.

Superior Comfort Claims

The National Advertising Division (NAD) reviewed the challenged claims that Oasys Max provides superior comfort and superior all-day comfort versus DAILIES TOTAL1® (DT1). NAD found that JJVC’s study was not a good fit for these claims because the study design did not adequately control for factors that could affect subjective comfort assessments.

NAD recommended that the claims be discontinued or modified to avoid conveying the unsupported message that typical users of Oasys Max lenses will notice meaningful and consistently perceivable comfort benefits over DT1 lenses.

“2x More Likely” Claims

NAD reviewed the challenged claims that, versus DT1 wearers, Oasys Max wearers are “2x more likely” to be satisfied with end-of-day comfort and to wear lenses comfortably as long as desired. JJVC based these claims on the same study that NAD found was not a good fit for the challenged comparative comfort claims.

NAD found that JJVC’s odds-ratio analysis did not establish that the proportion of Oasys Max wearers experiencing the stated comfort benefits was twice the proportion of DT1 wearers. Therefore, NAD recommended that the claims be discontinued or modified to avoid conveying the unsupported message that the 2x claims relating to end of day comfort and length of wear were based on actual clinical results.

“MAX comfort. MAX clarity.”

NAD found that the challenged claim “MAX comfort. MAX clarity,” in the context of the ECP brochure, communicated a comparison to Oasys 1-Day, not to DT1 or the broader daily disposable contact lens market. NAD determined that JJVC had a reasonable basis for that claim when used with a disclosure identifying Oasys 1-Day as the comparator.

During the proceeding, JJVC voluntarily discontinued certain challenged claims, including comparative vision claims. NAD did not review those claims on the merits and will treat them, for compliance purposes, as though NAD recommended their discontinuance and JJVC agreed to comply.

In its advertiser statement, JJVC stated that though it “disagrees with certain NAD conclusions,” it “agrees to comply with NAD’s recommendations.”

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. This press release shall not be used for advertising or promotional purposes.

About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than 20 globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, promote fair competition for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.

About the National Advertising Division: The National Advertising Division of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. The National Advertising Division reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and promoting fair competition for business.

New York, NY – April 17, 2026 – In a challenge brought by The Farmer’s Dog, Inc., BBB National Programs’ National Advertising Division found certain Sundays for Dogs air-dried dog food advertising claims related to nutrient retention, ingredient quality, and price were supported, but recommended that other comparative, ingredient, health, and “Made in USA” claims be discontinued or modified.

At issue for the National Advertising Division (NAD) were claims featured on the Sundays for Dogs website and social media channels regarding the benefits of air-drying, ingredient quality, and the cost-effectiveness of the product compared to frozen alternatives.

Air-Drying and Nutrient Claims

NAD reviewed air-drying and nutrient claims including that Sundays’ air-drying process “locks in peak flavors and nutrients better than kettle cooking,” preserves the “maximum amount of nutrients,” and results in superior nutrition compared to other cooking methods.

NAD found that the challenged social media claim, “Uses gentle air drying to keep the nutrients from the real meat, fruit, and veggies intact. Sundays doesn’t need to add a bunch of fake stuff back in because the good stuff from wholesome all-natural ingredients is still there” was supported. 

However, because the evidence did not support comparative superiority, NAD recommended that Sundays discontinue the claims that its process preserves more nutrients or flavor than other cooking methods or preserves the “maximum” amount of nutrients.

The No Additives Claims/Whole Ingredient Claims

NAD reviewed claims such as “all natural ingredients,” “100% meat and superfoods,” “the same ingredients you’d put in your salad,” and accompanying imagery suggesting the inclusion of whole fruits and vegetables.

NAD determined that, in context, these claims and images could reasonably convey the message that whole fruits and vegetables are included in the final product. Because Sundays uses nutrient extracts rather than whole foods, NAD recommended that these claims be discontinued or modified to avoid misleading consumers.

NAD found that certain claims, including that Sundays uses “real food ingredients” and “all-natural ingredients,” were supported.

NAD also found that Sundays’ monadic claims regarding “no synthetic additives” were supported. However, NAD recommended that Sundays discontinue the unsupported comparative claims suggesting that competing products contain synthetic additives.

Superlative Claims

NAD reviewed Sundays’ claim that it offers “what we think is the world’s healthiest, and most convenient dog food.”

NAD determined that this claim conveys an objective message of superiority in specific attributes—health and convenience—that requires substantiation. Because Sundays did not provide evidence demonstrating superiority over a significant portion of the market, NAD recommended that the claim be discontinued.

Price Comparison Claims

Sundays claimed its products are “up to 55% less pricey” than frozen dog foods. NAD found that this claim was supported when compared to the average price of frozen dog food products and that an appreciable number of consumers could achieve the advertised savings.

However, NAD also determined that the evidence did not support that level of savings for implied comparisons to The Farmer’s Dog, and recommended that Sundays clearly and conspicuously disclose that the comparison is to an average of frozen dog foods.

“Made in USA” Claims

NAD reviewed Sundays’ unqualified “Made in USA” claims. Although most ingredients are sourced domestically, certain key ingredients, including beef bone and fish oil, are sourced from New Zealand.

Consistent with Federal Trade Commission guidance, NAD determined that because these ingredients are essential to the product’s function, an unqualified “Made in USA” claim is not appropriate, even if the amount of foreign content is small. NAD recommended that Sundays discontinue the unqualified claim and modify it to include appropriate qualifications.

During the inquiry, Sundays for Dogs voluntarily discontinued certain claims. NAD will treat these claims for compliance purposes as though it recommended they be discontinued and Sundays agreed to comply.

In its advertiser statement, Sundays for Dogs stated it “agrees to comply with NAD’s recommendations.”

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. This press release shall not be used for advertising or promotional purposes.

About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than 20 globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, promote fair competition for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.

About the National Advertising Division: The National Advertising Division of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. The National Advertising Division reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and promoting fair competition for business.

New analysis highlights sharp rise in consumer protection class actions, shifting venue dynamics, and increasing concentration among repeat litigants and firms.

San Jose, CA — April 16, 2026 — LexisNexis^® Legal & Professional today announced the release of the Lex Machina^® 2026 Class Action Litigation Report, delivering a comprehensive, data-driven analysis of class action litigation trends in federal courts. Drawing on powerful data and exclusive insights from Lex Machina, the LexisNexis® Legal Analytics^® platform, the report examines key developments from 2023 through 2025, with additional historical context dating back to 2016.

Key findings from the report include:

• Class action filings reach decade high: After years of relative stability, federal class action filings surged in 2025 to more than 12,200 cases, marking the highest volume in the past decade. This increase reflects renewed litigation activity following pandemic-era disruptions and signals sustained momentum in the years.

• Consumer protection cases drive growth: Consumer protection class actions have emerged as the leading driver of federal litigation, accounting for nearly half of all filings over the past decade. In 2025 alone, these cases exceeded 7,600 filings, representing a nearly 50 percent year-over-year increase and fueling the broader rise in class actions.

• Substantial damage awards and litigation timelines underscore financial stakes: From 2023 through 2025, courts approved more than $32 billion in class action settlement damages, highlighting the significant financial exposure associated with these cases. Class certification and settlements typically occurred more than two years after filing, while trials on median took closer to four years.

“Lex Machina gives transactional attorneys (like me) a data-driven window into how deals play out if they were to end up in litigation,” said Eric Andalman, partner at Hogan Lovells. The platform “helps assess each party’s risk, understand how specific clauses have been litigated, and negotiate with clarity as to the real world consequences behind the contractual provisions.”

“Lex Machina provides crucial timing analytics, including data on key case milestones, that have transformed our approach to forecasting, calendaring, and legal budgeting,” said Mary Parker, associate attorney at Fields Han Cunniff. “Relying on these timing metrics perfectly supplements our traditional research and gives our firm a competitive edge.”

“Our Class Action Litigation Report helps legal teams assess the rising class action risk,” said Eric Wright, senior vice president for Lex Machina at LexisNexis. “As filings increase, customers need clear insight into where cases are being filed, how they are progressing, who the key players are, and where financial exposure is rising. Lex Machina helps firms and in-house counsel assess risk earlier, forecast timing more accurately, budget with greater confidence, and pursue smarter litigation and settlement strategies.”

To request a copy of the report, visit LexisNexis.com/LexMachina.  

The Lex Machina Legal Analytics platform equips litigation professionals to develop stronger case strategies and generate business. From precise timing metrics that inform legal budgeting to trend data on top law firms and leading judges, Lex Machina supplements traditional legal research and experience with customized, data-backed insights. These insights help lawyers identify and pursue new matters, navigate motion and trial strategies, and negotiate smarter settlements, ultimately giving firms a competitive edge in litigation.

About LexisNexis® Legal & Professional 

LexisNexis® Legal & Professional provides AI-powered legal, regulatory, business information, analytics and workflows that help customers increase their productivity, improve decision-making, achieve better outcomes, and advance the rule of law around the world. As a digital pioneer, the company was the first to bring legal and business information online with its Lexis® and Nexis® services. LexisNexis Legal & Professional, which serves customers in more than 150 countries with 11,900 employees worldwide, is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers.

About Lex Machina 

Lex Machina® fundamentally changes how companies and law firms compete in the business and practice of law. The company provides strategic insights on judges, lawyers, law firms, parties, and other critical information across 22 federal practice areas and a rapidly growing number of state courts. Lex Machina allows law firms and companies to anticipate the behaviors and outcomes that different legal strategies will produce, supporting more effective case strategy and business development efforts.

Lex Machina was named Winner of the “Overall LegalTech Data Solution Provider of the Year” LegalTech Breakthrough Award 2025, “Best Data Analytics & Insight Solution” 2025 CODiE Award, and Winner of the “Media Excellence Award” for Analytics/Big Data 2024. Based in Silicon Valley, Lex Machina is part of LexisNexis®, a leading global provider of legal, regulatory, and business information and analytics. For more information, please visit https://www.lexisnexis.com/en-us/products/lex-machina.page.

Eric Andalman and Mary Parker are customers of Lex Machina.

Media Contact

Venture PR lexmachina@venturepr.co 

New York, NY – April 14, 2026 – Following a BBB National Programs’ National Advertising Division challenge brought by GuruNanda, LLC, Writesy LLC d/b/a Dr.Dent voluntarily discontinued claims for its Purple Whitening Strips.

GuruNanda and Dr.Dent each market and sell teeth whitening strips. GuruNanda challenged express and implied claims made on product packaging, in TikTok videos, and on the Dr.Dent website and Amazon.com regarding, among other things, the benefits, efficacy, and safety of Dr.Dent’s Purple Whitening Strips.

During the inquiry, Dr.Dent informed NAD that it had permanently discontinued the challenged claims. Therefore, NAD did not review the claims on their merits and will treat the discontinued claims, for compliance purposes, as though NAD recommended they be discontinued.

In its advertiser statement, Dr.Dent stated that it “respects the self-regulatory process and thanks NAD for its time.”

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. This press release shall not be used for advertising or promotional purposes.

About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than 20 globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, promote fair competition for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.

About the National Advertising Division: The National Advertising Division of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. The National Advertising Division reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and promoting fair competition for business.

New York, NY – April 8, 2026 – In a Fast-Track SWIFT challenge brought by T-Mobile US, Inc., BBB National Programs’ National Advertising Division determined that Verizon Communications Inc. provided adequate disclosure of a future price increase in connection with its “four lines for $25/line” wireless service offer.

Fast-Track SWIFT is an expedited process for single-issue advertising cases reviewed by the National Advertising Division (NAD).

At issue for NAD was whether Verizon’s video and online advertising adequately disclosed that its $25 per line pricing is a 36-month promotional rate that increases to $30 per line after the promotional period.

NAD found that, unlike short-term “teaser” offers that lead to dramatic price hikes after only a few months, the three-year price and future increase aligns with reasonable consumer expectations that wireless rates may adjust over the long term.

As the offer was not coupled with a “perpetual guarantee” or messaging suggesting the price would never change, NAD determined that the future $5 per month per line increase was not a material term requiring more prominent disclosure than what Verizon already provided. Therefore, NAD concluded that the challenged advertising required no modification to the disclosures.

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. This press release shall not be used for advertising or promotional purposes.

About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than 20 globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, promote fair competition for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.

About the National Advertising Division: The National Advertising Division of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. The National Advertising Division reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and promoting fair competition for business.

Ann Arbor, MI — Motawi Tileworks, the Ann Arbor-based maker of handcrafted ceramic art tile, is introducing Second Studio, a new line of employee-designed tiles that expands the company’s design tradition and reflects its commitment to the Small Giants philosophy—building a company that strives to be great, not huge.

The first release in the series, Jellyfish, was designed by Motawi artist Ronan Sampson and selected from more than 60 entries in an internal art competition. The 4×8 tile features a spiraling, flowing composition that captures the delicate tension of its subject—both graceful and quietly electric with motion—and can be installed in any orientation.

Second Studio marks the first time in the company’s 30+ year history that Motawi will release a series of designs not created by founder and artistic director Nawal Motawi, but by the artists who make the tiles every day—those pressing clay, glazing basins, and firing kilns across the studio. New designs in the line will be released quarterly.

The initiative grew out of employee interest in participating more directly in the design process. Entries were reviewed by a panel of judges and then opened to company-wide voting across Motawi Tileworks and its sister company and clay supplier, Rovin Ceramics.

For Motawi, the program represents both a creative expansion and a long-term investment in the company’s future.

“I’m not going anywhere, but I’m not going to be around forever,” said Nawal Motawi. “The company needs to be able to move forward with different aesthetic stewardship someday. Second Studio is a way of including more people in that process so that the eventual hand-off becomes a natural progression. Most of the tilemaking staff has artistic backgrounds, so it’s natural for them to have design ideas. I hope our public loves them even more than mine.”

The connection between making and designing is central to the Second Studio concept. As Motawi artist Alexis Ellison, whose design will be released next, explains, “Spending so much time glazing changes the way you draw—you start thinking in the language of the tile.”

Ellison’s tile, currently in development, will be the second release in the series.

Karen Kromrei, General Manager of Motawi Tileworks, led the organization of the competition. “We talk a lot about ownership here—not just of tasks, but of the work itself,” Kromrei said. “This competition let people see their creative fingerprints on the future of the line. When the voting opened up, you could feel the energy. Everyone had a favorite.”

Founded in 1992, Motawi Tileworks produces handcrafted ceramic tile inspired by Art Nouveau, Arts and Crafts, and Midcentury Modern design. Each tile is made using the centuries-old Cuenca technique, with glazes applied by hand to create distinctive, dimensional surfaces.

The first Second Studio tile, Jellyfish, is currently available for sale on Motawi’s website and in its Gallery. To view the collection, visit:
https://www.motawi.com/collections/art-tile?utm_source=press_release&utm_medium=referral&utm_campaign=second_studio_launch

More information about Motawi Tileworks is available at:
https://www.motawi.com/?utm_source=press_release&utm_medium=referral&utm_campaign=second_studio_launch

Media Contact:

Greg Anderson
Marketing Coordinator
Motawi Tileworks
grega@motawi.com
(734) 213-0017 x 253

New York, NY – March 31, 2026 – Following a challenge brought by OLLY PBC, BBB National Programs’ National Advertising Division recommended that Bayer HealthCare LLC discontinue or modify certain claims for its One A Day^® Men’s Pre-Conception Health Complete Multivitamin, a product marketed for men who are trying to conceive.

OLLY and Bayer are competitors in the dietary supplement market. OLLY challenged Bayer’s claims that Bayer’s One A Day Men’s Pre-Conception Health Complete Multivitamin supports healthy sperm and contains “powerful” antioxidants, including lycopene, as well as Bayer’s use of the term “complete multivitamin.”

The National Advertising Division (NAD) found that certain claims, including that men should take the product for at least three months before conception and that the product is specially designed to provide nutritional support while trying to conceive, reasonably convey the message that the product improves men’s chances of conception.

NAD also found that, in the fertility-focused context, certain claims that the product supports healthy sperm reasonably convey the message that the product improves sperm health and viability.

NAD found that the ingredient testing in the record did not support the challenged claims and recommended that Bayer discontinue or modify these claims to avoid conveying the unsupported message that the Men’s Pre-Conception Health Complete Multivitamin will improve chances of conception or that it improves sperm health and viability.

NAD also reviewed Bayer’s claim that the product contains “powerful antioxidants including Vitamin C, Vitamin E, selenium, zinc, and Lycopene which support healthy sperm.” NAD found that this claim conveys the message that the identified nutrients are responsible for delivering the claimed sperm-related benefits and that lycopene exhibits powerful antioxidant activity in the product.

Because the evidence did not support those messages, NAD recommended that Bayer discontinue or modify the claim.

With respect to Bayer’s use of the term “complete multivitamin,” NAD concluded that, in the absence of extrinsic evidence demonstrating consumer confusion caused by the product name, it would not recommend a change to the product name.

In its advertiser statement, Bayer stated that it will comply with NAD’s recommendations.

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. This press release shall not be used for advertising or promotional purposes.

About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than 20 globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, promote fair competition for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.

About the National Advertising Division: The National Advertising Division of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. The National Advertising Division reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and promoting fair competition for business.

New York, NY – March 31, 2026 – Following a challenge brought by Reus Research LLC, BBB National Programs’ National Advertising Division recommended that Iron Rock Ventures LLC modify or discontinue certain claims for its thinbi NAD⁺ dietary supplement. As Iron Rock did not provide an advertiser’s statement confirming that it will comply with the National Advertising Division (NAD) recommendations, Iron Rock will be referred to the appropriate regulatory authorities for review and possible enforcement action.

Iron Rock and Reus compete in the dietary supplement market, each offering products related to NAD⁺ supplementation. Reus challenged certain claims relating to the ingredient content of the thinbi NAD⁺ product appearing on labeling, Amazon product detail pages, and Instagram posts.

“8,457MG” Claim

NAD found that consumers are likely to interpret the “8,457MG” statement on the front label and in related advertising as conveying that the product contains 8,457 mg of active dietary ingredients per capsule.

Although Iron Rock argued that consumers would look to the Supplement Facts Panel (SFP) for the product’s actual ingredient amounts, NAD found that the information contained in the SFP cannot effectively qualify an express claim when it contradicts that claim. Therefore, NAD recommended that Iron Rock discontinue the “8,457MG” claim and avoid conveying that the thinbi NAD⁺ product contains 8,457 mg of active dietary ingredients.

Equivalence Claims

NAD also reviewed claims that certain concentrated botanical extracts in the product were “equivalent to” much larger amounts of green tea leaf, turmeric root, and grape seed, as well as the implied message that the product as a whole is equivalent or comparable to one containing 8,457 mg of dietary ingredients and delivers the same health benefits and efficacy.

NAD found the record did not support those claims and recommended that Iron Rock discontinue the challenged “equivalent to” claims when made outside the SFP.

NAD⁺ Content Claim

NAD found that, in the context of certain Instagram posts, consumers could reasonably interpret the prominently displayed “8,457MG” statement as representing an amount of NAD⁺. Because the thinbi NAD⁺ product contains 150 mg of NAD⁺ per capsule, NAD recommended that Iron Rock modify its advertising to avoid conveying that the product contains 8,457 mg of NAD⁺.

Because Iron Rock did not provide an advertiser statement confirming that it will comply with NAD’s recommendations or appeal the decision, NAD will refer Iron Rock to the appropriate regulatory authorities, including the relevant state Attorneys General pursuant to Section 5.1(A) of the NAD/NARB Procedures as well as platforms on which the advertising appeared and with which NAD has a reporting relationship.

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. This press release shall not be used for advertising or promotional purposes

About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than 20 globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, promote fair competition for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.

About the National Advertising Division: The National Advertising Division of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. The National Advertising Division reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and promoting fair competition for business.